Alice Yu
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $16,275 of the $26,991 with a category attached, or 60.3%. Angiodynamics, Inc. accounts for 82.5% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2024 at $18,517 and has fallen 97.9% since, to $390 in 2025. Among urology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 81 payments — averaging $333.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$22K
- EDAP Technomed Inc$3K
- AstraZeneca$252
- Merck$222
- Koelis Inc.$186
- Astellas Pharma US Inc$181
- plus $703 from 9 others
Across 39 payments — averaging $3940.74 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Angiodynamics, Inc.$154K
What the payments were for
- Consulting fees$16,27560%
- Speaking & faculty fees$2231%
- Travel & lodging$6,89426%
- Food & beverage$3,59913%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 35 | $22,255 |
| EDAP Technomed Inc | 27 | $3,192 |
| AstraZeneca | 4 | $252 |
| Merck | 3 | $222 |
| Koelis Inc. | 1 | $186 |
| Astellas Pharma US Inc | 2 | $181 |
| Baxter Healthcare | 1 | $125 |
| Blue Earth Diagnostics | 1 | $125 |
| Telix Pharmaceuticals | 1 | $118 |
| Penumbra, Inc. | 1 | $116 |
| KARL Storz Endoscopy-america | 1 | $88 |
| Photocure Inc | 1 | $48 |
| Ferring Pharmaceuticals Inc. | 1 | $37 |
| Progenics Pharmaceuticals, Inc. | 1 | $26 |
| BD | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$26,991 in reported general payments places this provider in the 90th percentile of 935 urology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 39 | $141 |
| Oxybutynin Chloride | 14 | $56 |
Paid to pharmacies, not to this prescriber.
Other urology in Tampa
- Rafael CarrionTampa$240K
- Raviender BukkapatnamTampa$115K
- Trushar PatelTampa$88K
- Paul PeritoCoral Gables$3.6M
- Scott SellingerTallahassee$2.3M
- Mark Anthony GonzalgoMiami$1M
- Edward GheilerHialeah$655K
- Rolando RiveraNaples$437K
- Matthew ErcolaniVenice$416K
- Olubayo TojuolaOrlando$283K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.